We consider that these inconsistencies with BMMCs might be due to the existence of complex interactions between NK cells and leukemia cells in the AML BM microenvironment, and that NK cell maturation and functional performance depend on the binding of TIM-3 with its ligands. The gene discussed is HAVCR2; the disease is leukemia.